Excelsior Medical Co., Ltd. (TPE:4104)
81.70
+0.10 (0.12%)
At close: Dec 3, 2025
Excelsior Medical Revenue
Excelsior Medical had revenue of 2.19B TWD in the quarter ending September 30, 2025, with 6.44% growth. This brings the company's revenue in the last twelve months to 8.79B, up 4.04% year-over-year. In the year 2024, Excelsior Medical had annual revenue of 8.54B with 3.71% growth.
Revenue (ttm)
8.79B
Revenue Growth
+4.04%
P/S Ratio
1.60
Revenue / Employee
63.67M
Employees
138
Market Cap
14.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.54B | 305.14M | 3.71% |
| Dec 31, 2023 | 8.23B | 1.05B | 14.56% |
| Dec 31, 2022 | 7.19B | 613.68M | 9.34% |
| Dec 31, 2021 | 6.57B | -102.34M | -1.53% |
| Dec 31, 2020 | 6.68B | 218.13M | 3.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |